N-PORT filing recap · January 2021

What did ARK Genomic Revolution ETF buy in January 2021?

Reported stock-position changes between this filing and the previous one. These are ARK Genomic Revolution ETF's own holdings, not the firm's.

Stock value

$10.70B

Positions

Estimated turnover

99.7%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

RHHBYRoche Holding AG$393.85Mreported value+9.07M shares BMYBristol-Myers Squibb Company$164.06Mreported value+2.67M shares VEEVVeeva Systems Inc.$163.77Mreported value+592.4K shares GOOGLAlphabet Inc.$146.67Mreported value+80.3K shares SRPTSarepta Therapeutics, Inc.$145.20Mreported value+1.62M shares LGVWLongview Acquisition Corp.$35.40Mreported value+1.92M shares MASS908 Devices Inc.$30.74Mreported value+557.7K shares ONEM1life Healthcare Inc$13.40Mreported value+264.9K shares HIMSHims & Hers Health, Inc.$8.74Mreported value+460.1K shares

Increased positions

TDOCTeladoc Health, Inc.$854.46Mreported value+2.76M shares+582.2%TWSTTwist Bioscience Corporation$601.00Mreported value+1.98M shares+118.0%PACBPacific Biosciences of California, Inc.$578.95Mreported value+2.62M shares+17.2%EXASExact Sciences Corporation$426.85Mreported value

Reduced positions

CRSPCrispr Therapeutics AG$377.98Mreported value-278.9K shares-10.9%NVTAInvitae Corp$302.60Mreported value-165.8K shares-2.6%NTLAIntellia Therapeutics, Inc.$134.90Mreported value-255.4K shares-10.6%EDITEditas Medicine, Inc.$109.91Mreported value-234.8K shares

Exited positions

ILMNIllumina, Inc.$68.70Mprior reported value-234.7K shares-100.0%AAPLApple Inc.$33.1Kprior reported value-304 shares-100.0%